Shagun Singh
Stock Analyst at RBC Capital
(3.42)
# 975
Out of 5,090 analysts
243
Total ratings
52.74%
Success rate
2.02%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintains: Outperform | $95 → $100 | $86.19 | +16.02% | 24 | Dec 5, 2025 | |
| PODD Insulet | Maintains: Outperform | $370 → $380 | $304.49 | +24.80% | 4 | Nov 21, 2025 | |
| MDT Medtronic | Maintains: Outperform | $111 → $118 | $101.36 | +16.42% | 22 | Nov 19, 2025 | |
| OM Outset Medical | Maintains: Sector Perform | $22 → $17 | $4.39 | +287.24% | 14 | Nov 11, 2025 | |
| TFX Teleflex | Maintains: Sector Perform | $135 → $120 | $120.50 | -0.41% | 23 | Nov 7, 2025 | |
| GMED Globus Medical | Maintains: Outperform | $88 → $92 | $91.10 | +0.99% | 6 | Nov 7, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Sector Perform | $211 → $202 | $193.96 | +4.15% | 3 | Nov 7, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $111 → $101 | $94.28 | +7.13% | 17 | Nov 6, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $150 → $125 | $136.81 | -8.63% | 7 | Nov 4, 2025 | |
| DXCM DexCom | Maintains: Outperform | $100 → $85 | $65.49 | +29.79% | 5 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $615 → $625 | $575.34 | +8.63% | 17 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $147 | $125.08 | +17.52% | 17 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $125 | $97.52 | +28.18% | 17 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $25 | $20.92 | +19.50% | 3 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $330 → $325 | $300.66 | +8.10% | 15 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $185 | $201.93 | -8.38% | 22 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $4 → $3 | $0.89 | +237.08% | 8 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $364.02 | +19.50% | 19 | Jan 29, 2025 |
Edwards Lifesciences
Dec 5, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $86.19
Upside: +16.02%
Insulet
Nov 21, 2025
Maintains: Outperform
Price Target: $370 → $380
Current: $304.49
Upside: +24.80%
Medtronic
Nov 19, 2025
Maintains: Outperform
Price Target: $111 → $118
Current: $101.36
Upside: +16.42%
Outset Medical
Nov 11, 2025
Maintains: Sector Perform
Price Target: $22 → $17
Current: $4.39
Upside: +287.24%
Teleflex
Nov 7, 2025
Maintains: Sector Perform
Price Target: $135 → $120
Current: $120.50
Upside: -0.41%
Globus Medical
Nov 7, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $91.10
Upside: +0.99%
Becton, Dickinson and Company
Nov 7, 2025
Maintains: Sector Perform
Price Target: $211 → $202
Current: $193.96
Upside: +4.15%
Zimmer Biomet Holdings
Nov 6, 2025
Maintains: Outperform
Price Target: $111 → $101
Current: $94.28
Upside: +7.13%
Inspire Medical Systems
Nov 4, 2025
Maintains: Outperform
Price Target: $150 → $125
Current: $136.81
Upside: -8.63%
DexCom
Oct 31, 2025
Maintains: Outperform
Price Target: $100 → $85
Current: $65.49
Upside: +29.79%
Oct 22, 2025
Maintains: Outperform
Price Target: $615 → $625
Current: $575.34
Upside: +8.63%
Oct 16, 2025
Reiterates: Outperform
Price Target: $147
Current: $125.08
Upside: +17.52%
Sep 29, 2025
Reiterates: Outperform
Price Target: $125
Current: $97.52
Upside: +28.18%
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $20.92
Upside: +19.50%
Jul 30, 2025
Maintains: Outperform
Price Target: $330 → $325
Current: $300.66
Upside: +8.10%
Jul 17, 2025
Maintains: Outperform
Price Target: $181 → $185
Current: $201.93
Upside: -8.38%
Jul 15, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $0.89
Upside: +237.08%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $364.02
Upside: +19.50%